Department of Endocrinology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Consultant Endocrinologist, Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India.
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S83-S85. doi: 10.1016/j.ihj.2023.12.012. Epub 2023 Dec 29.
Lipid disorders are common in several endocrine conditions. Diabetes mellitus, hypothyroidism and Cushing's syndrome are the common endocrine disorders with dyslipidemia. Dyslipidemia has a significant impact on endocrine and metabolic health and the risk of atherosclerotic cardiovascular disease. In most cases of dyslipidemia, the suspicion of endocrine diseases must be based on clinical symptoms and signs. Optimal management of the dyslipidemia requires treatment of the underlying endocrine condition. Lipid lowering therapy is a useful adjunct or a requirement in many cases. The Indian guidelines provide a pragmatic and practical approach to the management of lipid disorders in endocrine disease, as well as endocrine vigilance with lipid therapy.
脂代谢紊乱在多种内分泌疾病中较为常见。糖尿病、甲状腺功能减退症和库欣综合征是常见的伴发脂代谢紊乱的内分泌疾病。脂代谢紊乱对内分泌和代谢健康以及动脉粥样硬化性心血管疾病风险有重要影响。在大多数脂代谢紊乱的情况下,对内分泌疾病的怀疑必须基于临床症状和体征。内分泌疾病脂代谢紊乱的最佳管理需要治疗基础的内分泌情况。降脂治疗在许多情况下是一种有用的辅助治疗或必需治疗。印度指南为内分泌疾病的脂代谢紊乱管理以及脂代谢治疗中的内分泌监测提供了一种实用和实际的方法。